GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38001271.
- Also identified by DOI 10.1038/s41591-023-02634-8 and PMC identifier 12320759.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.
Medical subject headings
- Diabetes Mellitus, Type 2
- Substance-Related Disorders